王林, 董永明. 可逆性胆碱酯酶抑制剂二甲氨基甲酸-3-(烷氨基)烷氧基-4(5)-叔丁基苯酯的合成J. 药学学报, 1988, 23(3): 213-217.
引用本文: 王林, 董永明. 可逆性胆碱酯酶抑制剂二甲氨基甲酸-3-(烷氨基)烷氧基-4(5)-叔丁基苯酯的合成J. 药学学报, 1988, 23(3): 213-217.
L Wang, YM Dong. SYNTHESIS OF 3-(ALKYLAMINO) ALKOXY-4(5)-t-BUTYLPHENYL N, N-DIMETHYLCARBAMATES AS REVERSIBLE CHOLINESTERASE INHIBITORSJ. Acta Pharmaceutica Sinica, 1988, 23(3): 213-217.
Citation: L Wang, YM Dong. SYNTHESIS OF 3-(ALKYLAMINO) ALKOXY-4(5)-t-BUTYLPHENYL N, N-DIMETHYLCARBAMATES AS REVERSIBLE CHOLINESTERASE INHIBITORSJ. Acta Pharmaceutica Sinica, 1988, 23(3): 213-217.

可逆性胆碱酯酶抑制剂二甲氨基甲酸-3-(烷氨基)烷氧基-4(5)-叔丁基苯酯的合成

SYNTHESIS OF 3-(ALKYLAMINO) ALKOXY-4(5)-t-BUTYLPHENYL N, N-DIMETHYLCARBAMATES AS REVERSIBLE CHOLINESTERASE INHIBITORS

  • Abstract: A series of 3-(dialkylamino) alkoxy-4 (5)-t-butylphenyl N, N-dimethylcarbamates(Ⅰ and Ⅱ), which are the nuclear alkylated derivatives of 3-(2-dimethylamino) ethoxyphenyl N, N-dimethylcarbamate (CUI XING AN) was prepared as potential anticholinesterase agents. Preliminary screening tests showed that the introduction of t-butyl group in CUI XING AN and its homologs decreased the toxicity and anticholinesterase activity. Compounds of type Ⅰ have increased protective activity against organophosphorus poisoning.

     

/

返回文章
返回